ArticleAging2022

A circadian rhythm-related biomarker for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma.

Yuanjun Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.